In October last year, we hosted our first ever i3 conference in North America. We enjoyed the event so much that i3 is back again this year – and this time, there are two… One in Austin, and one in Prague! So, if you’re based in North America, why...
Pharmaceutical companies are under escalating pressure to significantly increase the number of drugs that reach the market within a shorter timeframe, but lack the infrastructure to do so. More than ever, companies need to partner with outside firms to compress the timeline of drug development, thereby decreasing overall cost...
At the dawn of bioprocess development, biopharmaceutical manufacturing, upstream and downstream primary processing were worlds apart. This is because, in the pre-biotech days of industrial bioprocessing, the professionals in upstream, usually biologists, microbiologists, biochemists, and chemists, worked independently from the downstream professionals who were mostly chemical engineers working on...
Understanding the volume and complexity of data created throughout the scientific process is key. Biopharmaceutical companies generate a vast amount of high-value process data that is typically stored in paper records, databases, electronic files and in the heads of key personnel. This makes obtaining an holistic view of the...
These are exciting times in biologics. Since 1995, applications for biotech patents have increased 25% year-on-year and biologics currently make up more than 50% of drugs in development. And, with many big deals already on the ledger this year, 2018 is on track to be a popular one in...
The quality of your bioanalytical process will determine the quality of your study and with the right solution, the entire process can flow with a seamless assurance. As the primary impact on your study timeline occurs during the audit and review phase, isn’t it best to pick a solution...
Strict regulations, tight budgets and changing compliance needs are forcing pharma companies to employ new technology. Many are turning to cloud technology because it provides true scalability and helps free up time and resources that can be refocused on mission-critical or strategic projects. The resulting productivity, alongside the operational...
Whilst capturing and recording valid and accurate data is important for any company in any sector, it’s essential for businesses operating in the Research and Development (R&D) industry. Recording and working with data that could potentially contribute to life-changing discoveries means that there really isn’t any room for unreliable...
The amount of data that’s generated every day is staggering. According to an article published in Forbes magazine: “The volume of data is exploding. More data has been created in the past two years than in the entire previous history of the human race.” With that in mind then,...
According to research revealed earlier this year, “the global LIMS (Laboratory Information Management Systems) market is expected to reach USD $1,155.67 million by 2025, from USD $650.7 million in 2017.” This predicts a CAGR (Compound Annual Growth Rate) of 7.7% in the forecast period. Technology is undoubtedly growing at...
